NCT02791945View on ClinicalTrials.gov

N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Traumatic Brain Injury (TBI)Hazardous and Harmful Alcohol Use
Interventions
BEHAVIORAL

Medical Management Counseling

Brief alcohol counseling

DRUG

N-acetylcysteine

Experimental supplement

DRUG

Placebo

Placebo comparator

Trial Locations (1)

94121

San Francisco VA Medical Center, San Francisco

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Northern California Institute of Research and Education

OTHER

collaborator

San Francisco Veterans Affairs Medical Center

FED

collaborator

Institute for Translational Neuroscience

UNKNOWN

lead

University of California, San Francisco

OTHER

NCT02791945 - N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI | Biotech Hunter | Biotech Hunter